Structural Biology in Cancer Research
Structural Biology in Cancer Research
The major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modeling mainly aims at drug designing. Eventually, many researchers in Structural biology carry out cancer research to extend the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies. Cancer immunotherapy is also used which is defined as the response of immune system to reject cancer. Immunotherapies can be a better way of treating cancer. The malignant tumor cells are attacked by stimulating the immune system as these cells are responsible to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumor-associated antigens (TAAs).
-
Antibody Therapy
-
Cellular Immunotherapy
-
Cytokine Therapy
-
Combinational Immunotherapy
Related Conference of Structural Biology in Cancer Research
Structural Biology in Cancer Research Conference Speakers
Recommended Sessions
- Computational Approaches in Structural Biology
- Structural Biology Complexity Arenas
- 3D Structure Determination
- Biomolecules
- Drug Designing
- Frontiers in Structural Biology
- Hybrid Approaches for Structure Prediction
- Molecular Modeling & Dynamics
- Recent Advances in Structural Biology
- Sequencing
- Signalling Biology
- Structural Bioinformatics and Proteomics
- Structural Biology and Single Molecules
- Structural Biology Databases
- Structural Biology in Cancer Research
- Structural Molecular Biology
- Structural Virology

